Search

 
 
 
Eli Lilly to Pursue mRNA Cancer Vaccines with CureVac Pact

ELI LILLY TO PURSUE MRNA CANCER VACCINES WITH CUREVAC PACT

Eli Lilly is getting a foothold in messenger RNA cancer vaccines through a deal with CureVac that could develop up to five new therapies....

 
 
 

CUREVAC TO PRESENT AT THE J.P. MORGAN 35TH ANNUAL HEALTHCARE CONFERENCE 2017

TUBINGEN, Germany, Dec. 28, 2016 /PRNewswire/ - CureVac, a clinical-stage biopharmaceutical company pioneering the field of mRNA-based...